Indiana University Melvin and Bren Simon Cancer is a clinical research site located in Indianapolis, Indiana, United States 46202.
Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.
Indiana University Melvin and Bren Simon Cancer has participated in 2 clinical trials.
Therapeutic areas: Pancreatic Adenocarcinoma, Carcinoma, Pancreatic Ductal.
Sponsors: ImmunoGenesis, Sumitomo Pharma America, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Indiana · View every site in Indianapolis
Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Indiana University Melvin and Bren Simon Cancer has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Indiana University Melvin and Bren Simon Cancer has 2 clinical trials on record. Their work covers Pancreatic Adenocarcinoma, Carcinoma, Pancreatic Ductal.
Indiana University Melvin and Bren Simon Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.